Patiromer-an Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis.
Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas.
Michael
M
Emmett
Ankit
A
Mehta
D002118:Calcium; D006801:Humans; D006947:Hyperkalemia; D011108:Polymers; D011188:Potassium
D011108:Polymers; C568789:patiromer; D011188:Potassium; D002118:Calcium
Calcium; Dietary; Polymers; Potassium; calcium; chronic kidney disease; electrolytes; patiromer; phosphate uptake; potassium channels
Gruy-Kapral C, Emmett M, Santa Ana CA, Porter JL, Fordtran JS, Fine KD: Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 9: 1924–1930, 1998
Harel Z, Harel S, Shah PS, Wald R, Perl J, Bell CM: Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Am J Med 126: 264.e9–264.e24, 2013
Bushinsky DA, Spiegel DM, Gross C, Benton WW, Fogli J, Hill Gallant KM, Du Mond C, Block GA, Weir MR, Pitt B: Effect of Patiromer on Urinary Ion Excretion in Healthy Adults. Clin J Am Soc Nephrol 11: 1769–1776, 2016
Patel L, Bernard LM, Elder GJ: Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials. Clin J Am Soc Nephrol 11: 232–244, 2016
Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RT: Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 382: 1268–1277, 2013
Schiller LR, Santa Ana CA, Sheikh MS, Emmett M, Fordtran JS: Effect of the time of administration of calcium acetate on phosphorus binding. N Engl J Med 320: 1110–1113, 1989
Bakris GL, Pitt B, Weir MR, Freeman MW, Mayo MR, Garza D, Stasiv Y, Zawadzki R, Berman L, Bushinsky DA; AMETHYST-DN Investigators: Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial. JAMA 314: 151–161, 2015